Acceleron energy for sale

Acceleron Fusion Stock | Valuation, Funding, Investors | Notice

Acceleron Fusion stock might be available for purchase in the secondary markets, but Acceleron Fusion stock is not available for purchase by the general public, and can not be purchased

Read More

Is an Acquisition of Acceleron a Smart Move for Merck?

The ticker there for Acceleron is XLRN. Brian, assuming this deal does indeed materialize, do you think an acquisition of Acceleron is a smart move for Merck? Brian Orelli: Yeah.

Read More

Merck to Acquire Acceleron Pharma Inc.

Merck, known as MSD outside of the United States and Canada, and Acceleron Pharma Inc., a publicly traded biopharmaceutical company, announced that the companies have entered into a definitive

Read More

Acceleron Fusion Venture Capital and Private Equity Financings

Acceleron Fusion is a pioneer in muon-catalyzed fusion technology. The company spun out of NK Labs in 2023 after it was awarded two ARPA-E grants to research muon-catalyzed fusion

Read More

Acceleron Fusion Raises $15M for Cold Fusion Breakthrough

In an exciting development for the fusion energy sector, startup Acceleron Fusion has successfully raised $15 million in a funding round aimed at a total of $23.7 million. This surge in

Read More

Acceleron Fusion Secures $24M Series A Led by Lowercarbon

Acceleron Fusion, a pioneer in muon-catalyzed fusion energy, has closed a $24 million Series A funding round. The round was co-led by Lowercarbon Capital and Co...

Read More

Acceleron Secures $24 Million for Muon-Catalyzed Fusion Energy

Acceleron has announced $24 million in funding for its muon-catalyzed fusion reactor, which operates at 1,000° C, significantly cooler than traditional fusion methods that require

Read More

Merck to buy Acceleron for about $11.5 billion in rare disease

(Reuters) -Merck & Co said on Thursday it would buy Acceleron Pharma Inc for about $11.5 billion, broadening its portfolio beyond aging cancer drug Keytruda with potential treatments

Read More

Acceleron provides biggest biopharma deal this year, with $11.5B sale

Acceleron provides biggest biopharma deal this year, with $11.5B sale to Merck The acquisition is notable for Merck, which is under pressure to diversify its business beyond the cancer

Read More

People also like:

Get In Touch

Connect With Us

📧
📱

Phone

+27 71 897 0768

📍

Location

12735 okwakho st palmridge ext 8, Johannesburg, South Africa